Dr. Lloyd Damon, MD is a highly respected hematologist and researcher specializing in blood cancers such as lymphomas and leukemias. With a focus on personalized medicine, Dr. Damon takes a comprehensive approach to treating all blood diseases, both malignant and benign. He has made significant contributions to the field, including being an early investigator of rituximab, the first monoclonal antibody approved for cancer treatment, and developing innovative treatment regimens for mantle cell lymphoma and leukemia. Dr. Damon's expertise, compassion, and dedication to patient care have earned him a reputation as a top hematologist in San Francisco.
As a professor and deputy chief of the Divisions of Hematology and Medical Oncology at the University of California San Francisco (UCSF), Dr. Damon brings a wealth of knowledge and experience to his practice. He completed his medical degree at the University of Michigan and his residency and fellowship at UCSF. Board-certified in Hematology, Medical Oncology, and Internal Medicine, Dr. Damon is committed to providing the highest quality of care to his patients. With a focus on cutting-edge treatments and personalized approaches, he continues to make significant contributions to the field of hematology and oncology.
Generated from the website